Animal models of Huntington's disease (HD) that utilize 3-nitropropionic acid (3-NPA) in the initiation of oxidative stress
and accelerated brain-aging have been extensively studied. When administered to rodents, 3-NPA irreversibly...
During the development of potential protein or antibody therapeutics in a pharmaceutical environment, the use of animal models as test subjects is a necessary requirement. The dosing of mice, rats, and primates is essential to drug development...
Recently obesity in the United States has reached epidemic proportions. Significant morbidities associated with obesity include coronary artery disease (CAD) and obstructive sleep apnea (OSA). As a result, the growing needs of surgical procedures...
